Log in
Enquire now
Valneva SE

Valneva SE

Valneva SE is an antibody Discovery founded in 2013.

OverviewStructured DataIssuesContributors

Contents

valneva.com
valneva.com/en/
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Vaccine
Vaccine
Healthcare
Healthcare
Technology
Technology
Biotechnology
Biotechnology
Biology
Biology
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Location
Vienna
Vienna
0
United Kingdom
United Kingdom
Lyon
Lyon
France
France
Nantes
Nantes
Saint-Herblain
Saint-Herblain
0
Gaithersburg, Maryland
Gaithersburg, Maryland
Canada
Canada
...
B2X
B2B
B2B
0
B2C
B2C
CEO
‌
Thomas Lingelbach
0
Pitchbook URL
pitchbook.com/profiles.../57798-37
Legal Name
Valneva SE0
Legal classification
Societas Europaea
Societas Europaea
Number of Employees (Ranges)
501 – 1,000
Email Address
Phone Number
Full Address
6 rue Alain Bombard, 44800 Saint-Herblain, France0
CIK Number
1,836,5640
Place of Incorporation
France
France
0
Investors
MVM
MVM
Founded Date
2013
Total Funding Amount (USD)
51,721,320
Latest Funding Round Date
June 14, 2013
Business Model
Commerce
Stock Symbol
VALN0
Exchange
Nasdaq
Nasdaq
Patents Assigned (Count)
4
Legal Entity Identifier
969500DIVIP5VKNW49480
Country
France
France
0
Headquarters
Lyon
Lyon

Other attributes

Company Operating Status
Active
SIC Code
2,8360
Ticker Symbol
VALN0
Wikidata ID
Q20663010
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Valneva SE

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.